XTLB

XTL Biopharmaceuticals
XTLB

5 hedge funds and large institutions have $728K invested in XTL Biopharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38.3K
2
+$19.4K

Top Sellers

1
-$113K
2
-$203
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$559K
2
$110K
3
$38.3K
4
$19.5K
5
$843
6
–